Roxee Meds Catalog

Dexamethasone

Medication catalog facts with explicit FDA-approval, off-label, source-limited, and safety context.

Both Catalog complete FDA data linked Rx required Liquid (Solution) Multiple FDA labelers Official label facts Owner quick guide first

Start Symptom Intake Talk to a Vet / Find a Vet Near You

Veterinary professional?

Showing simplified owner view. Switch to Vet View for full technical detail.

Data freshness

Storefront facts

Catalog refreshed

May 5, 2026, 10:00 a.m.

These are the storefront facts Roxee uses on browse cards and quick facts.

FDA applications

FDA application data refreshed

May 5, 2026, 10:00 a.m.

Sponsor, product, and application records imported from Animal Drugs @ FDA.

Safety reports

Safety data refreshed

May 5, 2026, 10:01 a.m.

openFDA reaction terms and case summaries are supporting evidence, not proof of causality.

Source timing details

Storefront facts: Source Roxee | Refreshed May 5, 2026, 10:00 AM UTC
The storefront fact projection used for browse cards and quick facts.
Animal Drugs @ FDA: Source FDA | Refreshed May 5, 2026, 10:00 AM UTC
Applications/products are imported from FDA export data.
Animal Drugs @ FDA previews: Source FDA | Refreshed Feb 9, 2026, 3:05 AM UTC
Label highlights/doc links are fetched from FDA preview endpoints.
Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed May 5, 2026, 10:00 AM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
openFDA reaction terms: Source FDA openFDA | Refreshed May 5, 2026, 10:04 AM UTC
openFDA case summaries: Source FDA openFDA | Refreshed May 5, 2026, 10:04 AM UTC

Evidence

Reviewed / Updated / Sources

Reviewed by: Not available

Last reviewed: February 12, 2026

Updated: February 12, 2026, 10:44 PM UTC

Sources:

FDA application profile · official_label
FDA application profile · official_label
Medication usage source · fda_animal_drugs
Zonometh Solution · official_label
openFDA case USA-USFDACVM-2025-US-068758 · adverse_reaction

Image coming soon

Dexamethasone

Drug type: Generic ingredient • Branded profile • FDA branded products available

Both Liquid (Solution) Rx required 100% storefront ready

Species: Both

Manufacturer: Multiple FDA labelers

Medication Snapshot

Merged from the current Roxee medication system with field-level provenance, freshness, and completeness tracking.

Dexamethasone

In treatment of dogs as an anti-inflammatory agent. In treatment of cats as an anti-inflammatory agent. The drug is indicated for the treatment of primary bovine ketosis. Species commonly shown: Both, Dog, No Use Class Stated Or Implied, Horse, Not For Meat Production.

Generic name

Dexamethasone

Brand names

Dexamethasone Solution, Dexium®, Dexium-SP™, Dexamethasone Injection

Manufacturer

Multiple FDA labelers

Species

Both, Dog, No Use Class Stated Or Implied, Horse, Not For Meat Production, No Use Class Stated Or Implied

Dosage forms

Liquid (Solution), Injectable Solution, Tablet, Powder

Prescription

Prescription required

Completeness

100%

Validation

Complete

Brand names

Dexamethasone Solution Dexium® Dexium-SP™ Dexamethasone Injection Dexamethasone Sodium Phosphate Inj. Dex-A-Vet Injection Dexameth-A-Vet Injection Dexameth-A-Vet Dexamethasone Sterile Solution Dexachel Zonometh Solution Azium® Tablets 0.25 mg Azium® Aqueous Suspension Veterinary Azium® Solution Azium® Powder Azium® Boluses 10 mg Azium® Oral Solution 2 mg Dexium™ Tablets Pet Derm® III Tablets DEXAMETHASONE Dexamethasone SP Dexium DEXASONE Dexium-SP Dexamethasone Acetate Anhydrous

Dosage forms

Liquid (Solution) Injectable Solution Tablet Powder Bolus Liquid Tablet (Chewable)

Indications / Uses

In treatment of dogs as an anti-inflammatory agent. In treatment of cats as an anti-inflammatory agent. The drug is indicated for the treatment of primary bovine ketosis.

Warnings / Contraindications

Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy; and they may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Do not use in viral infections. Anti-inflammatory action of corticosteroids may mask signs of infections. Do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers, except for emergency therapy. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for use in horses intended for food.

Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy; and they may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Do not use in viral infections. Anti-inflammatory action of corticosteroids may mask signs of infections. Do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers, except for emergency therapy. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for use in horses intended for food.

Side Effects

Top reported reactions (openFDA): Vomiting, Lethargy (see also Central nervous system depression in 'Neurological'), Diarrhoea, Anaphylaxis, Death, Facial swelling (see also 'Skin').

FAQ

Both, Dog, No Use Class Stated Or Implied, Horse, Not For Meat Production, No Use Class Stated Or Implied, Cat, No Use Class Stated Or Implied, Horse, No Use Class Stated Or Implied, Dog, Restricted During Pregnancy

Yes. Roxee shows this as prescription-only.

Liquid (Solution), Injectable Solution, Tablet, Powder

Related Conditions

Congestive heart failure Dystocia Lameness (undifferentiated) Metritis

Source Transparency

Verified source: https://www.roxee.ai/meds/
Verified source: https://animaldrugsatfda.fda.gov
Verified source: https://animaldrugsatfda.fda.gov/adafda/views/#/search
Verified source: https://api.fda.gov/animalandveterinary/event.json
Verified source: https://www.roxee.ai/conditions/
Verified source: https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1245
Last refreshed: May 5, 2026, 10:00 a.m.
Last verified: Feb 12, 2026, 10:44 p.m.
Validation status: Complete

Add to My Pet's Meds

Choose a pet, confirm current or past, and optionally add reminder notes.

Pet Owner Quick Guide

Start here first for the safest next-step summary before the deeper medication detail.

Used for:

The drug is used as a rapid adrenal glucocorticoid and/or anti-inflammatory agent in horses.

Dosing note:

Exact dosing depends on your pet's species, weight, and health status. Use your veterinarian's instructions for the exact dose and schedule.

What to watch for:

Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy
and they may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis
Do not use in viral infections
Anti-inflammatory action of corticosteroids may mask signs of infections
Do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers, except for emergency therapy
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis
Not for use in horses intended for food
Vomiting (1 reports)
wobbly/unsteady walking (1 reports)
Loss of appetite (1 reports)

When to call the vet:

Repeated vomiting or diarrhea.
Severe lethargy (hard to wake, very low energy).
Collapse or fainting.
Trouble breathing.
Facial swelling or hives.
Blood in vomit or stool.

Regulatory restrictions are shown in Vet View.

What to tell or ask your vet today:

Is this medicine the right fit for my pet’s current symptoms?
Which warning signs mean I should call back right away?
How should I handle missed doses or refusal to take the medicine?

Major cautions & emergency warning signs

Side effects to monitor:

Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy
and they may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis
Do not use in viral infections
Anti-inflammatory action of corticosteroids may mask signs of infections
Do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers, except for emergency therapy

Most reported reactions:

Vomiting (1 reports)
Unsteady walking (ataxia) (1 reports)
Loss of appetite (1 reports)

Emergency warning signs:

Repeated vomiting or diarrhea.
Severe lethargy (hard to wake, very low energy).
Collapse or fainting.
Trouble breathing.

Talk to a Vet / Find a Vet Near You Start Symptom Intake

Quick Facts

Official label facts first, then secondary summaries. Marketing content is separated below.

Species: Both

Manufacturer: Multiple FDA labelers

Form: Bolus, Injectable Solution, Liquid, Liquid (Solution), Powder, Tablet

Identifiers:

ANADA: 200108 ANADA: 200312 ANADA: 200317 ANADA: 200324 ANADA: 200456 ANADA: 200565 NADA: 104606 NADA: 108687 NADA: 110046 NADA: 110349 NADA: 110350 NADA: 111369 NADA: 11885 NADA: 11901 NADA: 123815 NADA: 12559 NADA: 128089 NADA: 130660 NADA: 141598 NADA: 30136

Source metadata:

https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/200317 · official_label · FDA application profile
https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/200456 · official_label · FDA application profile
https://animaldrugsatfda.fda.gov · fda_animal_drugs · Medication usage source

Warnings / Contraindications

High: Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy; and they may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Do not use in viral infections. Anti-inflammatory action of corticosteroids may mask signs of infections. Do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers, except for emergency therapy. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for use in horses intended for food.

Source metadata:

https://animaldrugsatfda.fda.gov · fda_animal_drugs · Contraindication source

Adverse Reactions

Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.

Tap or hover a reaction to see what it means in plain language.

Tracked signals

Reported cases

Serious reports

Species represented

Grouped by Body System

Digestive (4) · Vomiting, Loss of appetite, Diarrhea Neurologic (1) · Unsteady walking (ataxia) Behavior (1) · Biting -aggression Other (26) · Elevated total bilirubin, Elevated temperature, Elevated serum alkaline phosphatase

Most Reported Reactions

Body system	Cases	Species	Serious cases
Digestive	1	Cat	1
Neurologic	1	Dog	1
Digestive	1	Dog	1
Other	1	Cat	1
Other	1	Dog	1
Other	1	Dog	1
Other	1	Cat	1
Other	1	Cat	1

Species coverage: Dog (21) Cat (11)

View detailed reaction table

Body system	Species	Seriousness	Frequency	Reports
Digestive	Cat	Serious	-	1
Neurologic	Dog	Serious	-	1
Digestive	Dog	Serious	-	1
Other	Cat	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Other	Cat	Serious	-	1
Other	Cat	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Digestive	Dog	Serious	-	1
Other	Cat	Serious	-	1
Other	Cat	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Digestive	Cat	Non-serious	-	1
Other	Dog	Serious	-	1
Other	Cat	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Behavior	Dog	Serious	-	1
Other	Cat	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Other	Cat	Serious	-	1
Other	Cat	Non-serious	-	1
Other	Dog	Serious	-	1

Source metadata:

https://api.fda.gov/animalandveterinary/event.json · adverse_reaction · openFDA case USA-USFDACVM-2025-US-068758

Documents

Owner handouts and official technical documents open on-page first, with the original source still one click away.

Owner handouts

No owner handouts linked yet.

Official label / PI

No official label or package insert links yet.

SPL

FOI

Dexium-SP™

SPL · SPL

Open original

FDA Structured Product Label

Dexium-SP™

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Bimeda Animal Health Limited
ANADA: 200-317
Status: RX
Form: Injectable Solution
Route: Intravenous
Species: No Use Class Stated Or Implied

Composition / specifications

Each milliliter contains 4.0 milligrams of dexamethasone sodium phosphate (equivalent to 3.0 milligrams dexamethasone).

Horses

Indication

The drug is used as a rapid adrenal glucocorticoid and/or anti-inflammatory agent in horses.

Dosage

The drug is administered intravenously at a dosage of 2.5 to 5.0 milligrams. If permanent corticosteroid effect is required, oral therapy may be substituted. When therapy is withdrawn after prolonged use, the daily dose should be reduced gradually over several days.

Limitations

Dexamethasone Solution

SPL · SPL

Open original

FDA Structured Product Label

Dexamethasone Solution

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Med-Pharmex, Inc.
ANADA: 200-456
Status: RX
Form: Injectable Solution
Route: Intravenous, Intramuscular
Species: No Use Class Stated Or Implied • No Use Class Stated Or Implied

Composition / specifications

Each milliliter of solution contains 2 milligrams dexamethasone.

Cattle

Indication

For the treatment of primary bovine ketosis and as an anti-inflammatory agent.

Dosage

5 to 20 milligrams depending on the severity of the condition administered intravenously or intramuscularly. Dosage may be repeated if necessary.

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Horses

Indication

For use as an anti-inflammatory agent.

Dosage

2.5 to 5 milligrams depending on the severity of the condition administered intravenously or intramuscularly. Dosage may be repeated if necessary.

Limitations

Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Zonometh Solution

SPL · SPL

Open original

FDA Structured Product Label

Zonometh Solution

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Huvepharma EOOD
NADA: 128-089
Status: RX
Form: Liquid (Solution)
Route: Intravenous, Intramuscular
Species: Dog, No Use Class Stated Or Implied • Horse, Not For Meat Production • Cat, No Use Class Stated Or Implied

Composition / specifications

The drug is a sterile aqueous solution. Each milliliter contains 2.0 milligrams of dexamethasone

Dogs

Indication

The drug is used as an anti-inflammatory agent.

Dosage

0.25 to 1 milligrams administered intravenously or intramuscularly.

Limitations

Cats

Indication

The drug is used as an anti-inflammatory agent.

Dosage

0.125 to 0.5 milligrams administered intravenously or intramuscularly.

Limitations

Horses

Indication

The drug is used as an anti-inflammatory agent.

Dosage

2.5 to 5 milligrams administered intravenously or intramuscularly.

Limitations

Dexameth-A-Vet

SPL · SPL

Open original

FDA Structured Product Label

Dexameth-A-Vet

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Bimeda Animal Health Limited
NADA: 99607
Status: RX
Form: Liquid (Solution)
Route: Intravenous
Species: Horse, Not For Meat Production

Composition / specifications

The drug is a sterile aqueous solution. Each milliliter contains either 2.0 milligrams of dexamethasone or 4.0 milligrams of dexamethasone sodium phosphate (equivalent to 3.0 milligrams of dexamethasone).

Horses

Indication

The drug is used as a rapid adrenal glucocorticoid and/or anti-inflammatory agent.

Dosage

Limitations

Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Dexameth-A-Vet Injection

SPL · SPL

Open original

FDA Structured Product Label

Dexameth-A-Vet Injection

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Bimeda Animal Health Limited
NADA: 99606
Status: RX
Form: Liquid (Solution)
Route: Intravenous
Species: Dog, No Use Class Stated Or Implied

Composition / specifications

Dogs

Indication

The drug is used in dogs for the treatment of inflammatory conditions, as supportive therapy in canine posterior paresis, as supportive therapy before or after surgery to enhance recovery of poor surgical risks, and as supportive therapy in nonspecific dermatosis.

Dosage

The drug is administered intravenously at 0.25 to 1 milligram initially. The dose may be repeated for 3 to 5 days or until a response is noted. If continued treatment is required, oral therapy may be substituted. When therapy is withdrawn after prolonged use, the daily dose should be reduced gradually over several days.

Limitations

Dex-A-Vet Injection

SPL · SPL

Open original

FDA Structured Product Label

Dex-A-Vet Injection

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Bimeda Animal Health Limited
NADA: 99604
Status: RX
Form: Liquid (Solution)
Route: Intravenous
Species: Horse, Not For Meat Production

Composition / specifications

The drug is a sterile aqueous solution. Each milliliter contains 4.0 milligrams of dexamethasone sodium phosphate (equivalent to 3.0 milligrams of dexamethasone).

Horses

Indication

The drug is used as a rapid adrenal glucocorticoid and/or anti-inflammatory agent in horses.

Dosage

Limitations

Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Dex-A-Vet Injection

SPL · SPL

Open original

FDA Structured Product Label

Dex-A-Vet Injection

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Bimeda Animal Health Limited
NADA: 99605
Status: RX
Form: Liquid (Solution)
Route: Intravenous
Species: Dog, No Use Class Stated Or Implied

Composition / specifications

The drug is a sterile aqueous solution. Each milliliter contains 4.0 milligrams of dexamethasone sodium phosphate (equivalent to 3.0 milligrams dexamethasone).

Dogs

Indication

Dosage

Limitations

Dexium®

SPL · SPL

Open original

FDA Structured Product Label

Dexium®

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Bimeda Animal Health Limited
ANADA: 200-312
Status: RX
Form: Liquid (Solution)
Route: Intramuscular, Intravenous
Species: Dog, No Use Class Stated Or Implied • Horse, No Use Class Stated Or Implied • No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied

Composition / specifications

Each milliliter contains 2 milligrams of dexamethasone.

Horses

Indication

The drug is indicated as an anti-inflammatory agent in horses.

Dosage

2.5 to 5 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.

Limitations

Cattle

Indication

The drug is indicated as an anti-inflammatory agent in cattle.

Dosage

5 to 20 milligrams depending on the severity of the condition administered intravenously or intramuscularly. Dosage may be repeated if necessary.

Limitations

Cats

Indication

The drug is indicated as an anti-inflammatory agent in cats.

Dosage

0.125 to 0.5 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.

Limitations

Dogs

Indication

The drug is indicated as an anti-inflammatory agent in dogs.

Dosage

0.25 to 1 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.

Limitations

Dexium™ Tablets

SPL · SPL

Open original

FDA Structured Product Label

Dexium™ Tablets

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Bimeda Animal Health Limited
NADA: 95218
Status: RX
Form: Tablet
Route: Oral
Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied

Composition / specifications

Each tablet contains 0.25 milligram of dexamethasone.

Cats

Indication

Dexamethasone is indicated for use as an anti-inflammatory agent

Dosage

Administer orally at 0.125 to 0.5 mg. per day up to 7 days

Limitations

Do not use in viral infections. Except for emergency therapy, do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome and peptic ulcers. Existence of congestive heart failure, diabetes and osteoporosis are relative contraindications. Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition if used during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Additionally, corticosteroids administered to dogs, rabbits and rodents during pregnancy have resulted in cleft palate in offspring. Corticosteroids administered to dogs during pregnancy have also resulted in other congenital anomalies including deformed forelegs, phocomelia and anasarca.

Dogs

Indication

Dexamethasone is indicated for use as an anti-inflammatory agent

Dosage

Administer orally at 0.25 to 1.25 mg. per day up to 7 days

Limitations

Dexamethasone Injection

SPL · SPL

Open original

FDA Structured Product Label

Dexamethasone Injection

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Watson Laboratories, Inc.
NADA: 104-606
Status: RX
Form: Liquid (Solution)
Route: Intravenous
Species: Dog, No Use Class Stated Or Implied • Horse, Not For Meat Production

Composition / specifications

The drug is a sterile aqueous solution. Each milliliter contains 4.0 milligrams of dexamethasone sodium phosphate (equivalent to 3.0 milligrams dexamethasone).

Dogs

Indication

The drug is used in dogs for the treatment of inflammatory conditions, as supportive therapy in canine posterior paresis as supportive therapy before or after surgery to enhance recovery of poor surgical risks, and as supportive therapy in nonspecific dermatosis.

Dosage

Limitations

Horses

Indication

The drug is used as a rapid adrenal glucocorticoid and/or anti-inflammatory agent in horses.

Dosage

Limitations

Dexamethasone Solution

SPL · SPL

Open original

FDA Structured Product Label

Dexamethasone Solution

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Huvepharma EOOD
ANADA: 200-108
Status: RX
Form: Liquid (Solution)
Route: Intravenous, Intramuscular
Species: Dog, No Use Class Stated Or Implied • Horse, Not For Meat Production • No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied

Composition / specifications

The drug is a sterile aqueous solution. Each milliliter contains 2 milligrams of dexamethasone.

Cats

Indication

The drug is indicated as an anti-inflammatory agent.

Dosage

0.125 to 0.5 milligrams depending on the severity of the condition. The drug is administered intravenously or intramuscularly and dosage may be repeated if necessary.

Limitations

Horses

Indication

The drug is indicated as an anti-inflammatory agent.

Dosage

2.5 to 5 milligrams depending on the severity of the condition. The drug is administered intravenously or intramuscularly and dosage may be repeated if necessary.

Limitations

Dogs

Indication

The drug is indicated as an anti-inflammatory agent.

Dosage

0.25 to 1 milligrams depending on the severity of the condition. The drug is administered intravenously or intramuscularly and dosage may be repeated if necessary.

Limitations

Cattle

Indication

The drug is indicated as an anti-inflammatory agent.

Dosage

5 to 20 milligrams depending on the severity of the condition. The drug is administered intravenously or intramuscularly and dosage may be repeated if necessary.

Limitations

Dexamethasone Sterile Solution

SPL · SPL

Open original

FDA Structured Product Label

Dexamethasone Sterile Solution

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Kinetic Technologies, LLC
NADA: 111-369
Status: RX
Form: Liquid (Solution)
Route: Intravenous, Intramuscular
Species: Dog, No Use Class Stated Or Implied • Horse, Not For Meat Production • Cat, No Use Class Stated Or Implied

Composition / specifications

The drug is a sterile aqueous solution. Each milliliter contains 2.0 milligrams of dexamethasone

Dogs

Indication

The drug is used as an anti-inflammatory agent.

Dosage

0.25 to 1 milligram administered intravenously or intramuscularly.

Limitations

Cats

Indication

The drug is used as an anti-inflammatory agent.

Dosage

0.125 to 0.5 milligrams administered intravenously or intramuscularly.

Limitations

Horses

Indication

The drug is used as an anti-inflammatory agent.

Dosage

2.5 to 5 milligrams administered intravenously or intramuscularly.

Limitations

Pet Derm® III Tablets

SPL · SPL

Open original

FDA Structured Product Label

Pet Derm® III Tablets

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Kinetic Technologies, LLC
NADA: 108-687
Status: RX
Form: Tablet (Chewable)
Route: Oral
Species: Dog, Restricted During Pregnancy

Composition / specifications

Each half-scored tablet contains 0.25 milligrams of dexamethasone.

Dogs

Indication

Supportive therapy in nonspecific dermatosis and inflammatory conditions.

Dosage

0.25 to 1.25 milligrams per day. Administer by free-choice feeding or crumble over food. Administer 0.25 to 1.25 milligrams daily in single or two divided doses until response is noted or 7 days have elapsed. When response is attained, dosage should be gradually reduced by 0.125 milligram per day until maintenance level is achieved.

Limitations

Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy, and they may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Do not use in viral infections. Anti-inflammatory action of corticosteroids may mask signs of infection. Do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers, except for emergency therapy. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Azium® Aqueous Suspension Veterinary

SPL · SPL

Open original

FDA Structured Product Label

Azium® Aqueous Suspension Veterinary

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Intervet, Inc.
NADA: 11901
Status: RX
Form: Liquid (Solution)
Route: Intramuscular, Intravenous
Species: Dog, No Use Class Stated Or Implied • Horse, Not For Meat Production • No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied

Composition / specifications

The drug is a sterile aqueous solution. Each milliliter contains 2 milligrams of dexamethasone.

Cattle

Indication

The drug is indicated for the treatment of primary bovine ketosis.

Dosage

5 to 20 milligrams depending on the severity of the condition administered intravenously or intramuscularly; the dosage may be repeated if necessary.

Limitations

Horses

Indication

The drug is indicated as an anti-inflammatory agent in horses.

Dosage

2.5 to 5 milligrams administered intravenously or intramuscularly; the dosage may be repeated if necessary.

Limitations

Cats

Indication

The drug is indicated as an anti-inflammatory agent in cats.

Dosage

0.125 to 0.5 milligrams administered intravenously or intramuscularly; the dosage may be repeated if necessary.

Limitations

Dogs

Indication

The drug is indicated as an anti-inflammatory agent in dogs.

Dosage

0.25 to 1 milligrams administered intravenously or intramuscularly; the dosage may be repeated if necessary.

Limitations

Azium® Boluses 10 mg

SPL · SPL

Open original

FDA Structured Product Label

Azium® Boluses 10 mg

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Intervet, Inc.
NADA: 30435
Status: RX
Form: Bolus
Route: Oral
Species: Horse, No Use Class Stated Or Implied • No Use Class Stated Or Implied

Composition / specifications

Each bolus is half-scored and contains 10 milligrams of dexamethasone.

Cattle

Indication

Dexamethasone bolus is indicated in cases where cattle require additional steroid therapy following its parenteral administration. The drug may be used as supportive therapy for management of inflammatory conditions such as acute arthritic lameness; and for various stress conditions where corticosteroids are required while the animal is being treated for a specific condition.

Dosage

Administered orally, 5 to 10 milligrams for the first day, then 5 milligrams per day as required.

Limitations

Do not use in viral infections during the viremic stage. With bacterial infections, appropriate antibacterial therapy should be used. Do not use in animals with chronic nephritis and hypercorticalism (cushingoid syndrome) except for emergency therapy. Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal.

Horses

Indication

Dexamethasone bolus is indicated in cases where horses require additional steroid therapy following its parenteral administration. The drug may be used as supportive therapy for management of inflammatory conditions such as acute arthritic lameness es; and for various stress conditions where corticosteroids are required while the animal is being treated for a specific condition.

Dosage

Administered orally, 5 to 10 milligrams for the first day, then 5 milligrams per day as required.

Limitations

Azium® Oral Solution 2 mg

SPL · SPL

Open original

FDA Structured Product Label

Azium® Oral Solution 2 mg

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Intervet, Inc.
NADA: 92835
Status: RX
Form: Liquid
Route: Oral
Species: Dog, No Use Class Stated Or Implied • Horse, No Use Class Stated Or Implied • No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied

Azium® Powder

SPL · SPL

Open original

FDA Structured Product Label

Azium® Powder

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Intervet, Inc.
NADA: 30434
Status: RX
Form: Powder
Route: Oral
Species: Horse, No Use Class Stated Or Implied • No Use Class Stated Or Implied

Composition / specifications

Dexamethasone powder is packaged in packets containing 10 milligrams of dexamethasone.

Cattle

Indication

Dexamethasone powder is indicated in cases where cattle require additional steroid therapy following its parenteral administration. The drug is used as supportive therapy for management or inflammatory conditions such as acute arthritic lameness; and for various stress conditions where corticosteroids are required while the animal is being treated for a specific condition.

Dosage

The drug is administered at a dosage level of 5 to 10 milligrams per animal the first day then 5 milligrams per day as required by drench or by sprinkling on a small amount of feed.

Limitations

Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal.

Horses

Indication

Dexamethasone powder is indicated in cases where horses require additional steroid therapy following its parenteral administration. The drug is used as supportive therapy for management or inflammatory conditions such as acute arthritic lameness; and for various stress conditions where corticosteroids are required while the animal is being treated for a specific condition.

Dosage

The drug is administered at a dosage level of 5 to 10 milligrams per animal the first day then 5 milligrams per day as required by drench or by sprinkling on a small amount of feed.

Limitations

Azium® Solution

SPL · SPL

Open original

FDA Structured Product Label

Azium® Solution

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Intervet, Inc.
NADA: 12559
Status: RX
Form: Liquid (Solution)
Route: Intramuscular, Intravenous
Species: Dog, No Use Class Stated Or Implied • Horse, Not For Meat Production • No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied

Composition / specifications

The drug is a sterile aqueous solution. Each milliliter contains 2 milligrams of dexamethasone.

Dogs

Indication

The drug is indicated as an anti-inflammatory agent in dogs.

Dosage

0.25 to 1 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.

Limitations

Cats

Indication

The drug is indicated as an anti-inflammatory agent in cats.

Dosage

0.125 to 0.5 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.

Limitations

Cattle

Indication

The drug is indicated as an anti-inflammatory agent in cattle.

Dosage

5 to 20 milligrams depending on the severity of the condition administered intravenously or intramuscularly. Dosage may be repeated if necessary.

Limitations

Horses

Indication

The drug is indicated as an anti-inflammatory agent in horses.

Dosage

2.5 to 5 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.

Limitations

Azium® Tablets 0.25 mg

SPL · SPL

Open original

FDA Structured Product Label

Azium® Tablets 0.25 mg

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Intervet, Inc.
NADA: 11885
Status: RX
Form: Tablet
Route: Oral
Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied

Composition / specifications

Each tablet contains 0.25 milligram of dexamethasone.

Dogs

Indication

In treatment of dogs as an anti-inflammatory agent.

Dosage

Administer orally at 0.25 to 1.25 milligrams per day for up to 7 days.

Limitations

Cats

Indication

In treatment of cats as an anti-inflammatory agent.

Dosage

Administer orally at 0.125 to 0.5 milligram per day for up to 7 days.

Limitations

Dexachel

SPL · SPL

Open original

FDA Structured Product Label

Dexachel

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Zoetis Inc.
NADA: 130-660
Status: RX
Form: Liquid (Solution)
Route: Intravenous
Species: Dog, No Use Class Stated Or Implied • Horse, Not For Meat Production • Cat, No Use Class Stated Or Implied

Composition / specifications

The drug is a sterile aqueous solution. Each milliliter contains 2.0 milligrams of dexamethasone

Dogs

Indication

The drug is used as an anti-inflammatory agent.

Dosage

0.25 to 1 milligrams administered intravenously.

Limitations

Cats

Indication

The drug is used as an anti-inflammatory agent.

Dosage

0.125 to 0.5 milligrams administered intravenously.

Limitations

Horses

Indication

The drug is used as an anti-inflammatory agent.

Dosage

2.5 to 5 milligrams administered intravenously.

Limitations

Dexamethasone Injection

SPL · SPL

Open original

This source does not expose a safe inline preview. Use the original source link for the full document.

Dexamethasone Injection

SPL · SPL

Open original

This source does not expose a safe inline preview. Use the original source link for the full document.

Dexamethasone Injection

SPL · SPL

Open original

FDA Structured Product Label

Dexamethasone Injection

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Sparhawk Laboratories, Inc.
ANADA: 200-324
Status: RX
Form: Liquid (Solution)
Route: Intravenous, Intramuscular
Species: Horse, No Use Class Stated Or Implied • No Use Class Stated Or Implied

Composition / specifications

Each milliliter contains 2 milligrams of dexamethasone.

Cattle

Indication

For the treatment of primary bovine ketosis and as an anti-inflammatory agent in cattle.

Dosage

5 to 20 milligrams depending on the severity of the condition administered intravenously or intramuscularly. Dosage may be repeated if necessary.

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Horses

Indication

The drug is indicated as an anti-inflammatory agent in horses.

Dosage

2.5 to 5 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Dexamethasone Sodium Phosphate Inj.

SPL · SPL

Open original

This source does not expose a safe inline preview. Use the original source link for the full document.

Dexamethasone Sodium Phosphate Inj.

SPL · SPL

Open original

FDA Structured Product Label

Dexamethasone Sodium Phosphate Inj.

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Cronus Pharma Specialities India Private Ltd.
NADA: 123-815
Status: RX
Form: Liquid (Solution)
Route: Intravenous
Species: Dog, No Use Class Stated Or Implied • Horse, Not For Meat Production

Composition / specifications

Specifications: The drug is a sterile aqueous solution. Each milliliter contains 4.0 milligrams of dexamethasone sodium phosphate (equivalent to 3.0 milligrams of dexamethasone).

Dogs

Indication

The drug is given for glucocorticoid and anti-inflammatory agent.

Dosage

0.25 to 1 milligram initially, administered intravenously. May be repeated for 3 to 5 days or until response is noted.

Limitations

If permanent glucocorticoid effect is required, oral therapy may be substituted. When therapy is to be withdraw after prolonged use, the daily dose should be reduced gradually over several days. Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Do not use in viral infections. Anti-inflammatory action of glucocorticoids may mask signs of infection. Except when used for emergency therapy, the product is contraindicated in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Horses

Indication

The drug is given for glucocorticoid and anti-inflammatory agent.

Dosage

FOI · FOI summary

Open original

Source metadata:

https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1065 · document · FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/156/Dexium-SP%E2%84%A2 · document · SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1176 · document · FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2572/Dexamethasone%20Solution · document · SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/512/Zonometh%20Solution · document · SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1924/Dexameth-A-Vet · document · SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1919/Dexameth-A-Vet%20Injection · document · SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1910/Dex-A-Vet%20Injection · document · SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1918/Dex-A-Vet%20Injection · document · SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1060 · document · FOI

Veterinary reference (advanced)

Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.

At a Glance

Quick facts and links to official labeling and safety signals.

Data freshness

Storefront facts: Source Roxee | Refreshed May 5, 2026, 10:00 AM UTC
The storefront fact projection used for browse cards and quick facts.
Animal Drugs @ FDA: Source FDA | Refreshed May 5, 2026, 10:00 AM UTC
Applications/products are imported from FDA export data.
Animal Drugs @ FDA previews: Source FDA | Refreshed Feb 9, 2026, 3:05 AM UTC
Label highlights/doc links are fetched from FDA preview endpoints.
Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed May 5, 2026, 10:00 AM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
openFDA reaction terms: Source FDA openFDA | Refreshed May 5, 2026, 10:04 AM UTC
openFDA case summaries: Source FDA openFDA | Refreshed May 5, 2026, 10:04 AM UTC

Official (FDA)

Identity: Generic ingredient • FDA branded products available

Official FDA brands: DEXAMETHASONE DEXASONE Dexamethasone Acetate Anhydrous Dexamethasone SP Dexium Dexium-SP

Manufacturer mapping: Multiple FDA labelers

Case-reported brands (openFDA): MSK

Catalog species: Both • FDA-labeled species: Cat, Dog, Horse, No Use Class Stated Or Implied

Rx/OTC: RX

Form/route: Bolus, Injectable Solution, Liquid, Liquid (Solution), Powder, Tablet, Tablet (Chewable) • Intramuscular, Intravenous, Oral

Applications: ANADA 200-317 • ANADA 200-456 • NADA 128-089 • NADA 99607 • NADA 99606 • NADA 99604 • NADA 99605 • ANADA 200-312 • NADA 95218 • NADA 104-606 • ANADA 200-108 • NADA 111-369 • NADA 108-687 • NADA 11901 • NADA 30435 • NADA 92835 • NADA 30434 • NADA 12559 • NADA 11885 • NADA 130-660 • NADA 110-349 • NADA 110-350 • ANADA 200-324 • NADA 110-046 • NADA 123-815

NDC: Packages 13985-043-29 13985-533-03 13985-533-25 46066-223-04 46066-223-80 50989-437-12 • Products 13985 46066 50989 57319 60270 61133

Documents: 5 (FOI: 5) • SPL: 25 • Label highlights • Official documents

Safety (openFDA)

Top reactions: Dog 56 • Cat 21 • View

Case summaries: 12 (showing 8) • View

openFDA reports are unverified and do not prove causation.

Explore

Related conditions: Congestive heart failure Dystocia Lameness (undifferentiated) Metritis

Linked using: Fda_Label (0.95), Fda_Label (0.95), Fda_Label (0.95)

Diagnosis Codes

ICD10_CM: H60.90

Otitis externa, unspecified ear

Counseling and Monitoring Highlights

Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.

Owner-facing counseling points

Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy; and they may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Do not use in viral infections. Anti-inflammatory action of corticosteroids may mask signs of infections. Do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers, except for emergency therapy. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for use in horses intended for food. (Contraindication, High)

Top reaction signals

Vomiting (1) Unsteady walking (ataxia) (1) Loss of appetite (1) Elevated total bilirubin (1) Elevated temperature (1) Elevated serum alkaline phosphatase (1) Elevated renal parameters (1) Elevated gamma-glutamyl transferase (1)

Identifiers & Packages

Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.

Identifiers

Package NDC	Product NDC	Status
0010-5587-01	0010	-
0010-5587-02	0010	-
0010-5587-03	0010	-
0010-5587-04	0010	-
13985-043-29	13985	-
13985-533-03	13985	-
13985-533-25	13985	-
46066-223-04	46066	-
46066-223-80	46066	-
50989-437-12	50989	-
57319-519-05	57319	-
60270-337-10	60270	-
61133-0892-9	61133	-
61133-0899-9	61133	-
73309-154-01	73309	-
73309-154-02	73309	-

Enriched Documents

Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.

DEXAMETHASONE SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
DEXAMETHASONE SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
DEXAMETHASONE SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
DEXASONE SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
Dexium-SP SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
DEXAMETHASONE SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
Dexium SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
Dexamethasone SP SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
Dexamethasone Acetate Anhydrous SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
FOI Summary oN 141-598 Approved April 10 2025_ceg_ef.pdf • FOI summary • Official • June 3, 2025
FDA FOI summary for application 141598
ucm061771.pdf • FOI summary • Official • April 1, 2024
FDA FOI summary for application 200317
UCM492475.pdf • FOI summary • Official • Dec. 26, 2023
FDA FOI summary for application 200456
ucm061765.pdf • FOI summary • Official • Oct. 2, 2018
FDA FOI summary for application 200312
A200108_Org_4_13_1995.pdf • FOI summary • Official • May 16, 2017
FDA FOI summary for application 200108
ucm061789.pdf • FOI summary • Official • June 1, 2016
FDA FOI summary for application 200324
UCM457231.pdf • FOI summary • Official • June 1, 2016
FDA FOI summary for application 200565

Data Sources & Change Log

Every non-trivial field is expected to include provenance and update timestamps.

Official 51 Clinical 1 Manufacturer 0 Marketing 0

Current Field Facts

side_effects: Top reported reactions (openFDA): Vomiting, Lethargy (see also Central nervous system depression in 'Neurological'), Diarrhoea, Anaphylaxis, Death, Facial swel… (Clinical, 2026-04-11)
contraindications: Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition … (Official, 2026-04-12)
contraindications: Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition … (Official, 2026-04-11)
contraindications: Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition … (Official, 2026-02-12)
indications: For the treatment of primary bovine ketosis and as an anti-inflammatory agent in cattle and horses. (Official, 2026-05-05)
indications: For the treatment of primary bovine ketosis and as an anti-inflammatory agent in cattle and horses. (Official, 2026-05-03)
indications: For the treatment of primary bovine ketosis and as an anti-inflammatory agent in cattle and horses. (Official, 2026-05-02)
indications: For the treatment of primary bovine ketosis and as an anti-inflammatory agent in cattle and horses. (Official, 2026-04-29)
indications: For the treatment of primary bovine ketosis and as an anti-inflammatory agent in cattle and horses. (Official, 2026-04-28)
indications: For the treatment of primary bovine ketosis and as an anti-inflammatory agent in cattle and horses. (Official, 2026-04-27)
indications: For the treatment of primary bovine ketosis and as an anti-inflammatory agent in cattle and horses. (Official, 2026-04-26)
indications: For the treatment of primary bovine ketosis and as an anti-inflammatory agent in cattle and horses. (Official, 2026-04-25)
indications: For the treatment of primary bovine ketosis and as an anti-inflammatory agent in cattle and horses. (Official, 2026-04-22)
manufacturer_name: Multiple FDA labelers (Official, 2026-05-05)
manufacturer_name: Multiple FDA labelers (Official, 2026-05-03)
manufacturer_name: Multiple FDA labelers (Official, 2026-05-02)
manufacturer_name: Multiple FDA labelers (Official, 2026-04-29)
manufacturer_name: Multiple FDA labelers (Official, 2026-04-28)
manufacturer_name: Multiple FDA labelers (Official, 2026-04-27)
manufacturer_name: Multiple FDA labelers (Official, 2026-04-26)

Recent Revisions

side_effects updated 2026-04-12 10:05 by etl_backfill • Backfilled from existing medication fields
contraindications updated 2026-04-12 10:05 by etl_backfill • Backfilled from existing medication fields
usage updated 2026-04-12 10:05 by etl_backfill • Backfilled from existing medication fields
side_effects updated 2026-04-11 10:05 by etl_backfill • Backfilled from existing medication fields
contraindications updated 2026-04-11 10:05 by etl_backfill • Backfilled from existing medication fields
usage updated 2026-04-11 10:05 by etl_backfill • Backfilled from existing medication fields
side_effects updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
contraindications updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
usage updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields

FDA Products & Applications (Animal Drugs @ FDA)

Official sponsor/proprietary-name/application-status records linked by active ingredient.

Product	Sponsor	Application	Status	Published
Dexium-SP™ RX Dexamethasone Sodium Phosphate Injectable Solution • Intravenous Label highlights Official documents	Bimeda Animal Health Limited	ANADA 200-317	Approved	Apr 1, 2024
Dexamethasone Solution RX Dexamethasone Injectable Solution • Intravenous, Intramuscular Label highlights Official documents	Med-Pharmex, Inc.	ANADA 200-456	W	Dec 26, 2023
Zonometh Solution RX Dexamethasone Liquid (Solution) • Intravenous, Intramuscular Label highlights Official documents	Huvepharma EOOD	NADA 128-089	Approved	Aug 7, 2019
Dexameth-A-Vet RX Dexamethasone Liquid (Solution) • Intravenous Label highlights Official documents	Bimeda Animal Health Limited	NADA 99607	Approved	Oct 2, 2018
Dexameth-A-Vet Injection RX Dexamethasone Liquid (Solution) • Intravenous Label highlights Official documents	Bimeda Animal Health Limited	NADA 99606	Approved	Oct 2, 2018
Dex-A-Vet Injection RX Dexamethasone Sodium Phosphate Liquid (Solution) • Intravenous Label highlights Official documents	Bimeda Animal Health Limited	NADA 99604	Approved	Oct 2, 2018
Dex-A-Vet Injection RX Dexamethasone Sodium Phosphate Liquid (Solution) • Intravenous Label highlights Official documents	Bimeda Animal Health Limited	NADA 99605	Approved	Oct 2, 2018
Dexium® RX Dexamethasone Liquid (Solution) • Intramuscular, Intravenous Label highlights Official documents	Bimeda Animal Health Limited	ANADA 200-312	Approved	Oct 2, 2018
Dexium™ Tablets RX Dexamethasone Tablet • Oral Label highlights Official documents	Bimeda Animal Health Limited	NADA 95218	Approved	Oct 2, 2018
Dexamethasone Injection RX Dexamethasone Sodium Phosphate Liquid (Solution) • Intravenous Label highlights Official documents	Watson Laboratories, Inc.	NADA 104-606	W	Jul 25, 2018
Dexamethasone Solution RX Dexamethasone Liquid (Solution) • Intravenous, Intramuscular Label highlights Official documents	Huvepharma EOOD	ANADA 200-108	Approved	May 16, 2017
Dexamethasone Sterile Solution RX Dexamethasone Liquid (Solution) • Intravenous, Intramuscular Label highlights Official documents	Kinetic Technologies, LLC	NADA 111-369	Approved	Nov 3, 2016
Pet Derm® III Tablets RX Dexamethasone Tablet (Chewable) • Oral Label highlights Official documents	Kinetic Technologies, LLC	NADA 108-687	Approved	Nov 3, 2016
Azium® Aqueous Suspension Veterinary RX Dexamethasone Liquid (Solution) • Intramuscular, Intravenous Label highlights Official documents	Intervet, Inc.	NADA 11901	Approved	Jun 1, 2016
Azium® Boluses 10 mg RX Dexamethasone Bolus • Oral Label highlights Official documents	Intervet, Inc.	NADA 30435	Approved	Jun 1, 2016
Azium® Oral Solution 2 mg RX Dexamethasone Liquid • Oral Official documents	Intervet, Inc.	NADA 92835	Approved	Jun 1, 2016
Azium® Powder RX Dexamethasone Powder • Oral Label highlights Official documents	Intervet, Inc.	NADA 30434	Approved	Jun 1, 2016
Azium® Solution RX Dexamethasone Liquid (Solution) • Intramuscular, Intravenous Label highlights Official documents	Intervet, Inc.	NADA 12559	Approved	Jun 1, 2016
Azium® Tablets 0.25 mg RX Dexamethasone Tablet • Oral Label highlights Official documents	Intervet, Inc.	NADA 11885	Approved	Jun 1, 2016
Dexachel RX Dexamethasone Liquid (Solution) • Intravenous Label highlights Official documents	Zoetis Inc.	NADA 130-660	Approved	Jun 1, 2016
Dexamethasone Injection RX Dexamethasone Sodium Phosphate Official documents	Watson Laboratories, Inc.	NADA 110-349	W	Jun 1, 2016
Dexamethasone Injection RX Dexamethasone Official documents	Watson Laboratories, Inc.	NADA 110-350	W	Jun 1, 2016
Dexamethasone Injection RX Dexamethasone Liquid (Solution) • Intravenous, Intramuscular Label highlights Official documents	Sparhawk Laboratories, Inc.	ANADA 200-324	Approved	Jun 1, 2016
Dexamethasone Sodium Phosphate Inj. RX Dexamethasone Sodium Phosphate Official documents	Akorn, Inc.	NADA 110-046	W	Jun 1, 2016
Dexamethasone Sodium Phosphate Inj. RX Dexamethasone Sodium Phosphate Liquid (Solution) • Intravenous Label highlights Official documents	Cronus Pharma Specialities India Private Ltd.	NADA 123-815	Approved	Jun 1, 2016

Data source: FDA Animal Drugs @ FDA (public search export).

What It's For (FDA Label Highlights)

Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.

Species: No Use Class Stated Or Implied

Composition / specifications

Each milliliter contains 4.0 milligrams of dexamethasone sodium phosphate (equivalent to 3.0 milligrams dexamethasone).

Horses

Indication

The drug is used as a rapid adrenal glucocorticoid and/or anti-inflammatory agent in horses.

Dosage

Limitations

FDA page: Open in Animal Drugs @ FDA

Species: No Use Class Stated Or Implied • No Use Class Stated Or Implied

Composition / specifications

Each milliliter of solution contains 2 milligrams dexamethasone.

Cattle

Indication

For the treatment of primary bovine ketosis and as an anti-inflammatory agent.

Dosage

5 to 20 milligrams depending on the severity of the condition administered intravenously or intramuscularly. Dosage may be repeated if necessary.

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Horses

Indication

For use as an anti-inflammatory agent.

Dosage

2.5 to 5 milligrams depending on the severity of the condition administered intravenously or intramuscularly. Dosage may be repeated if necessary.

Limitations

Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Horse, Not For Meat Production • Cat, No Use Class Stated Or Implied

Composition / specifications

The drug is a sterile aqueous solution. Each milliliter contains 2.0 milligrams of dexamethasone

Dogs

Indication

The drug is used as an anti-inflammatory agent.

Dosage

0.25 to 1 milligrams administered intravenously or intramuscularly.

Limitations

Cats

Indication

The drug is used as an anti-inflammatory agent.

Dosage

0.125 to 0.5 milligrams administered intravenously or intramuscularly.

Limitations

Horses

Indication

The drug is used as an anti-inflammatory agent.

Dosage

2.5 to 5 milligrams administered intravenously or intramuscularly.

Limitations

FDA page: Open in Animal Drugs @ FDA

Species: Horse, Not For Meat Production

Composition / specifications

Horses

Indication

The drug is used as a rapid adrenal glucocorticoid and/or anti-inflammatory agent.

Dosage

Limitations

Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied

Composition / specifications

Dogs

Indication

Dosage

Limitations

FDA page: Open in Animal Drugs @ FDA

Species: Horse, Not For Meat Production

Composition / specifications

The drug is a sterile aqueous solution. Each milliliter contains 4.0 milligrams of dexamethasone sodium phosphate (equivalent to 3.0 milligrams of dexamethasone).

Horses

Indication

The drug is used as a rapid adrenal glucocorticoid and/or anti-inflammatory agent in horses.

Dosage

Limitations

Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied

Composition / specifications

The drug is a sterile aqueous solution. Each milliliter contains 4.0 milligrams of dexamethasone sodium phosphate (equivalent to 3.0 milligrams dexamethasone).

Dogs

Indication

Dosage

Limitations

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Horse, No Use Class Stated Or Implied • No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied

Composition / specifications

Each milliliter contains 2 milligrams of dexamethasone.

Horses

Indication

The drug is indicated as an anti-inflammatory agent in horses.

Dosage

2.5 to 5 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.

Limitations

Cattle

Indication

The drug is indicated as an anti-inflammatory agent in cattle.

Dosage

5 to 20 milligrams depending on the severity of the condition administered intravenously or intramuscularly. Dosage may be repeated if necessary.

Limitations

Cats

Indication

The drug is indicated as an anti-inflammatory agent in cats.

Dosage

0.125 to 0.5 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.

Limitations

Dogs

Indication

The drug is indicated as an anti-inflammatory agent in dogs.

Dosage

0.25 to 1 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.

Limitations

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied

Composition / specifications

Each tablet contains 0.25 milligram of dexamethasone.

Cats

Indication

Dexamethasone is indicated for use as an anti-inflammatory agent

Dosage

Administer orally at 0.125 to 0.5 mg. per day up to 7 days

Limitations

Dogs

Indication

Dexamethasone is indicated for use as an anti-inflammatory agent

Dosage

Administer orally at 0.25 to 1.25 mg. per day up to 7 days

Limitations

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Horse, Not For Meat Production

Composition / specifications

The drug is a sterile aqueous solution. Each milliliter contains 4.0 milligrams of dexamethasone sodium phosphate (equivalent to 3.0 milligrams dexamethasone).

Dogs

Indication

Dosage

Limitations

Horses

Indication

The drug is used as a rapid adrenal glucocorticoid and/or anti-inflammatory agent in horses.

Dosage

Limitations

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Horse, Not For Meat Production • No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied

Composition / specifications

The drug is a sterile aqueous solution. Each milliliter contains 2 milligrams of dexamethasone.

Cats

Indication

The drug is indicated as an anti-inflammatory agent.

Dosage

0.125 to 0.5 milligrams depending on the severity of the condition. The drug is administered intravenously or intramuscularly and dosage may be repeated if necessary.

Limitations

Horses

Indication

The drug is indicated as an anti-inflammatory agent.

Dosage

2.5 to 5 milligrams depending on the severity of the condition. The drug is administered intravenously or intramuscularly and dosage may be repeated if necessary.

Limitations

Dogs

Indication

The drug is indicated as an anti-inflammatory agent.

Dosage

0.25 to 1 milligrams depending on the severity of the condition. The drug is administered intravenously or intramuscularly and dosage may be repeated if necessary.

Limitations

Cattle

Indication

The drug is indicated as an anti-inflammatory agent.

Dosage

5 to 20 milligrams depending on the severity of the condition. The drug is administered intravenously or intramuscularly and dosage may be repeated if necessary.

Limitations

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Horse, Not For Meat Production • Cat, No Use Class Stated Or Implied

Composition / specifications

The drug is a sterile aqueous solution. Each milliliter contains 2.0 milligrams of dexamethasone

Dogs

Indication

The drug is used as an anti-inflammatory agent.

Dosage

0.25 to 1 milligram administered intravenously or intramuscularly.

Limitations

Cats

Indication

The drug is used as an anti-inflammatory agent.

Dosage

0.125 to 0.5 milligrams administered intravenously or intramuscularly.

Limitations

Horses

Indication

The drug is used as an anti-inflammatory agent.

Dosage

2.5 to 5 milligrams administered intravenously or intramuscularly.

Limitations

FDA page: Open in Animal Drugs @ FDA

Species: Dog, Restricted During Pregnancy

Composition / specifications

Each half-scored tablet contains 0.25 milligrams of dexamethasone.

Dogs

Indication

Supportive therapy in nonspecific dermatosis and inflammatory conditions.

Dosage

Limitations

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Horse, Not For Meat Production • No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied

Composition / specifications

The drug is a sterile aqueous solution. Each milliliter contains 2 milligrams of dexamethasone.

Cattle

Indication

The drug is indicated for the treatment of primary bovine ketosis.

Dosage

5 to 20 milligrams depending on the severity of the condition administered intravenously or intramuscularly; the dosage may be repeated if necessary.

Limitations

Horses

Indication

The drug is indicated as an anti-inflammatory agent in horses.

Dosage

2.5 to 5 milligrams administered intravenously or intramuscularly; the dosage may be repeated if necessary.

Limitations

Cats

Indication

The drug is indicated as an anti-inflammatory agent in cats.

Dosage

0.125 to 0.5 milligrams administered intravenously or intramuscularly; the dosage may be repeated if necessary.

Limitations

Dogs

Indication

The drug is indicated as an anti-inflammatory agent in dogs.

Dosage

0.25 to 1 milligrams administered intravenously or intramuscularly; the dosage may be repeated if necessary.

Limitations

FDA page: Open in Animal Drugs @ FDA

Species: Horse, No Use Class Stated Or Implied • No Use Class Stated Or Implied

Composition / specifications

Each bolus is half-scored and contains 10 milligrams of dexamethasone.

Cattle

Indication

Dosage

Administered orally, 5 to 10 milligrams for the first day, then 5 milligrams per day as required.

Limitations

Horses

Indication

Dosage

Administered orally, 5 to 10 milligrams for the first day, then 5 milligrams per day as required.

Limitations

FDA page: Open in Animal Drugs @ FDA

Species: Horse, No Use Class Stated Or Implied • No Use Class Stated Or Implied

Composition / specifications

Dexamethasone powder is packaged in packets containing 10 milligrams of dexamethasone.

Cattle

Indication

Dosage

The drug is administered at a dosage level of 5 to 10 milligrams per animal the first day then 5 milligrams per day as required by drench or by sprinkling on a small amount of feed.

Limitations

Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal.

Horses

Indication

Dosage

The drug is administered at a dosage level of 5 to 10 milligrams per animal the first day then 5 milligrams per day as required by drench or by sprinkling on a small amount of feed.

Limitations

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Horse, Not For Meat Production • No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied

Composition / specifications

The drug is a sterile aqueous solution. Each milliliter contains 2 milligrams of dexamethasone.

Dogs

Indication

The drug is indicated as an anti-inflammatory agent in dogs.

Dosage

0.25 to 1 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.

Limitations

Cats

Indication

The drug is indicated as an anti-inflammatory agent in cats.

Dosage

0.125 to 0.5 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.

Limitations

Cattle

Indication

The drug is indicated as an anti-inflammatory agent in cattle.

Dosage

5 to 20 milligrams depending on the severity of the condition administered intravenously or intramuscularly. Dosage may be repeated if necessary.

Limitations

Horses

Indication

The drug is indicated as an anti-inflammatory agent in horses.

Dosage

2.5 to 5 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.

Limitations

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied

Composition / specifications

Each tablet contains 0.25 milligram of dexamethasone.

Dogs

Indication

In treatment of dogs as an anti-inflammatory agent.

Dosage

Administer orally at 0.25 to 1.25 milligrams per day for up to 7 days.

Limitations

Cats

Indication

In treatment of cats as an anti-inflammatory agent.

Dosage

Administer orally at 0.125 to 0.5 milligram per day for up to 7 days.

Limitations

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Horse, Not For Meat Production • Cat, No Use Class Stated Or Implied

Composition / specifications

The drug is a sterile aqueous solution. Each milliliter contains 2.0 milligrams of dexamethasone

Dogs

Indication

The drug is used as an anti-inflammatory agent.

Dosage

0.25 to 1 milligrams administered intravenously.

Limitations

Cats

Indication

The drug is used as an anti-inflammatory agent.

Dosage

0.125 to 0.5 milligrams administered intravenously.

Limitations

Horses

Indication

The drug is used as an anti-inflammatory agent.

Dosage

2.5 to 5 milligrams administered intravenously.

Limitations

FDA page: Open in Animal Drugs @ FDA

Species: Horse, No Use Class Stated Or Implied • No Use Class Stated Or Implied

Composition / specifications

Each milliliter contains 2 milligrams of dexamethasone.

Cattle

Indication

For the treatment of primary bovine ketosis and as an anti-inflammatory agent in cattle.

Dosage

5 to 20 milligrams depending on the severity of the condition administered intravenously or intramuscularly. Dosage may be repeated if necessary.

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Horses

Indication

The drug is indicated as an anti-inflammatory agent in horses.

Dosage

2.5 to 5 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Horse, Not For Meat Production

Composition / specifications

Specifications: The drug is a sterile aqueous solution. Each milliliter contains 4.0 milligrams of dexamethasone sodium phosphate (equivalent to 3.0 milligrams of dexamethasone).

Dogs

Indication

The drug is given for glucocorticoid and anti-inflammatory agent.

Dosage

0.25 to 1 milligram initially, administered intravenously. May be repeated for 3 to 5 days or until response is noted.

Limitations

Horses

Indication

The drug is given for glucocorticoid and anti-inflammatory agent.

Dosage

2.5 to 5 milligrams administered intravenously.

Limitations

If permanent glucocorticoid effect is required, oral therapy may be substituted. When therapy is to be withdraw after prolonged use, the daily dose should be reduced gradually over several days. Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Do not use in viral infections. Anti-inflammatory action of glucocorticoids may mask signs of infection. Except when used for emergency therapy, the product is contraindicated in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers. Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Usage

In treatment of dogs as an anti-inflammatory agent. In treatment of cats as an anti-inflammatory agent. The drug is indicated for the treatment of primary bovine ketosis.

Source: FDA Animal Drugs @ FDA • Reference

Contraindications

Top Reported Reactions (openFDA)

De-duplicated reaction terms grouped by body system from FDA openFDA reports (not verified; does not prove causation).

Digestive

Vomiting (1) • Cat Loss of appetite (1) • Dog Diarrhea (1) • Dog Decreased appetite (1) • Cat

Showing top 5 for Digestive.

Neurologic

Unsteady walking (1) • Dog

Showing top 5 for Neurologic.

Behavior

Biting -aggression (1) • Dog

Showing top 5 for Behavior.

Other

Elevated total bilirubin (1) • Cat Elevated temperature (1) • Dog Elevated serum alkaline phosphatase (1) • Dog Elevated renal parameters (1) • Cat Elevated gamma-glutamyl transferase (1) • Cat

Show more (21)

Elevated blood urea nitrogen (1) • Dog Elevated alanine aminotransferase (1) • Dog Dry mucous membrane (1) • Dog Diabetic ketoacidosis (1) • Cat Diabetes mellitus (1) • Cat Dermatitis (1) • Dog Dehydration (1) • Dog Decreased blood urea nitrogen (BUN) or creatinine (1) • Dog Death (1) • Dog Deafness (1) • Cat Constricted pupils (1) • Dog Circulatory collapse (1) • Dog Blood in urine (1) • Dog Azotaemia (1) • Cat Anaphylaxis (1) • Dog Anal sac disorder (1) • Dog Anaemia NOS (1) • Dog Agglutination test, positive (1) • Dog Abnormal ultrasound finding (1) • Cat Abnormal radiograph finding (1) • Cat Abnormal cytology (1) • Dog

Showing top 5 for Other.

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Adverse Event Case Summaries (openFDA)

These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.

Dog, ['Shepherd Dog - Australian', 'Poodle (unspecified)'], Male, 2 year, 24.131 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Polyuria, Soft stool, Vomiting • Outcome: Ongoing

Report ID: USA-USFDACVM-2025-US-075387
Serious AE: Yes
Treated For AE: Yes
Sex: Male
Age: 2.00 Year
Weight: 24.131 Kilogram

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Unknown
Form: Unassigned

Reactions Reported:

Polyuria Soft stool Vomiting

Outcomes: Ongoing

Dog, ['Terrier - Jack Russell', 'Terrier - Bull - American Pit'], Female, 1 year, 17.236 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Vomiting, Hives, Reddening of the skin, Skin irritation, Urine leakage… • Outcome: Ongoing

Report ID: USA-USFDACVM-2025-US-074361
Serious AE: Yes
Treated For AE: Yes
Sex: Female
Age: 1.00 Year
Weight: 17.236 Kilogram

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Unknown
Form: Unassigned

Reactions Reported:

Vomiting Hives Reddening of the skin Skin irritation Urine leakage Hypersensitivity reaction

Outcomes: Ongoing

Dog, Retriever - Labrador, Female, 8 year, 33.339 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Immune mediated haemolytic anaemia, Death, Anaemia NOS, Thrombocytopenia, Neutrophilia… • Outcome: Died

Report ID: USA-USFDACVM-2025-US-074459
Serious AE: Yes
Treated For AE: Yes
Sex: Female
Age: 8.00 Year
Weight: 33.339 Kilogram

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Unknown
Form: Unassigned

Reactions Reported:

Immune mediated haemolytic anaemia Death Anaemia NOS Thrombocytopenia Neutrophilia Heart murmur Vomiting Icterus Panting Not eating Other abnormal test result NOS Elevated alanine aminotransferase Elevated total bilirubin Elevated serum alkaline phosphatase Thrombocytosis Haemolysis NOS Medication error NOS Monocytosis Large platelets Spherocytosis Agglutination test, positive

Outcomes: Died

Dog, Shih Tzu, Female, 11.68 year, 6.53 kilogram • Drug: MSK, Parenteral • Reactions: Not eating, Periorbital oedema, Fever, Local swelling, Nasal discharge… • Outcome: Ongoing

Report ID: USA-USFDACVM-2025-US-074693
Serious AE: Yes
Treated For AE: Yes
Sex: Female
Age: 11.68 Year
Weight: 6.530 Kilogram

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Parenteral

Reactions Reported:

Not eating Periorbital oedema Fever Local swelling Nasal discharge Stridor Face and neck swelling Sneezing Respiratory tract disorder NOS Biting -aggression

Outcomes: Ongoing

Dog, Dachshund - Miniature, Female, 1 year, 2.812 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Circulatory collapse, Pale mucous membrane, Vomiting, Hives, Anaphylaxis • Outcome: Ongoing

Report ID: USA-USFDACVM-2025-US-074149
Serious AE: Yes
Treated For AE: Yes
Sex: Female
Age: 1.00 Year
Weight: 2.812 Kilogram

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Unknown
Form: Unassigned

Reactions Reported:

Circulatory collapse Pale mucous membrane Vomiting Hives Anaphylaxis

Outcomes: Ongoing

Cat, Domestic Shorthair, Male, 5 year, 4.536 kilogram • Drug: MSK, Unknown • Reactions: Limping, Weight loss, Paralysis NOS • Outcome: Outcome Unknown

Report ID: USA-USFDACVM-2025-US-073798
Serious AE: Yes
Treated For AE: No
Sex: Male
Age: 5.00 Year
Weight: 4.536 Kilogram

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Unknown

Reactions Reported:

Limping Weight loss Paralysis NOS

Outcomes: Outcome Unknown

Cat, Maine Coon, Male, 8 year, 5.942 kilogram • Drug: MSK, Injection, solution, Unknown • Reactions: Pain NOS, Lameness, Not eating, Fever, High pancreatic-specific lipase… • Outcome: Recovered/Normal

Report ID: USA-USFDACVM-2025-US-071120
Serious AE: No
Treated For AE: Yes
Sex: Male
Age: 8.00 Year
Weight: 5.942 Kilogram

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Unknown
Form: Injection, solution

Reactions Reported:

Pain NOS Lameness Not eating Fever High pancreatic-specific lipase Tiredness (lethargy) Vomiting Lack of efficacy - NOS

Outcomes: Recovered/Normal

Dog, Dachshund - Miniature, Female, 4 year, 5.557 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Vomiting, Lateral recumbency, Pale mucous membrane, Dry mucous membrane, Anaphylaxis… • Outcome: Recovered/Normal

Report ID: USA-USFDACVM-2025-US-070459
Serious AE: Yes
Treated For AE: Yes
Sex: Female
Age: 4.00 Year
Weight: 5.557 Kilogram

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Unknown
Form: Unassigned

Reactions Reported:

Vomiting Lateral recumbency Pale mucous membrane Dry mucous membrane Anaphylaxis Hives Swollen muzzle

Outcomes: Recovered/Normal

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Overdose Information

No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.

Storage & Handling

No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.

Share Your Thoughts

Let others know your experience or advice regarding this medication.

No community reviews yet. Be the first to share your experience.

This medication has not been reviewed by a veterinarian yet.

Medical Disclaimer: The medication details provided on Roxee are for informational purposes only and are not a substitute for professional veterinary advice. Always consult your veterinarian about your pet's specific needs.

Dexamethasone

Data freshness

Evidence

Dexamethasone

Medication Snapshot

Dexamethasone

Indications / Uses

Warnings / Contraindications

Side Effects

FAQ

What species is this commonly shown for?

Does this usually require a prescription?

What dosage forms are listed?

Related Conditions

Source Transparency

Add to My Pet's Meds

Pet Owner Quick Guide

Quick Facts

Warnings / Contraindications

Adverse Reactions

Grouped by Body System

Most Reported Reactions

Documents

Owner handouts

Official label / PI

SPL

FOI

Dexium-SP™

Dexium-SP™

Horses

Dexamethasone Solution

Dexamethasone Solution

Cattle

Horses

Zonometh Solution

Zonometh Solution

Dogs

Cats

Horses

Dexameth-A-Vet

Dexameth-A-Vet

Horses

Dexameth-A-Vet Injection

Dexameth-A-Vet Injection

Dogs

Dex-A-Vet Injection

Dex-A-Vet Injection

Horses

Dex-A-Vet Injection

Dex-A-Vet Injection

Dogs

Dexium®

Dexium®

Horses

Cattle

Cats

Dogs

Dexium™ Tablets

Dexium™ Tablets

Cats

Dogs

Dexamethasone Injection

Dexamethasone Injection

Dogs

Horses

Dexamethasone Solution

Dexamethasone Solution

Cats

Horses

Dogs

Cattle

Dexamethasone Sterile Solution

Dexamethasone Sterile Solution

Dogs

Cats

Horses

Pet Derm® III Tablets

Pet Derm® III Tablets

Dogs

Azium® Aqueous Suspension Veterinary